Synkir-310
DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation
Verismo TherapeuticsPhase 1
—
Rating in progress
Synkir-310 in DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active